Theofilos Charles Steve 13D and 13G filings for Akari Therapeutics, Plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-06-18 4:15 pm Purchase | 2024-05-31 | 13D | AKARI THERAPEUTICS PLC SPONSOR AKTX | Theofilos Charles Steve | 59,268,750 9.990% | 59,268,750 (New Position) | Filing |